BioWorld Asia

July 1, 2009

UK Committing £150M to Grow Biotech Innovation, Start-ups

LONDON — The UK government is putting in £150 million (US$248 million) as a cornerstone investor in what it hopes will become a £1 billion fund for biotech and other high-tech start-ups over the next 10 years. (BioWorld International) Read More

Clavis' Promising AML Data, Pipeline Helps Bring in $20M

Serotonin Linked to Maternal Behavior in Knockout Study

Alizyme Seeking Funds to Stay Afloat After Missed Milestones

Irish Translational Oncology Research Initiative Gets $7.8M

Cytox Boosting Biomarker Work in Alzheimer's with $1M Funding

Vectura Getting $7.5M Payment as NVA237 Starts Phase III Trial

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Dec. 27, 2024.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for December 24, 2024.

Illustration of neurons with Lewy bodies

Enhanced Cognition: Lewy body dementia phase II pumps stock

BioWorld

Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...

Experimental mRNA gene therapy suppresses preeclampsia in mice

BioWorld MedTech

A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...

Lab glassware and antibodies art concept

Probing bidirectional cancer-autoimmune link can yield new targets

BioWorld Science

Cancer and autoimmunity are “often thought of as being at opposite ends of the immune response,” Ana Anderson told her audience at a joint meeting of the NIH’s...